vimarsana.com

Latest Breaking News On - Anti tnf - Page 3 : vimarsana.com

Precision Blood Test PrismRA Receives Medicare Coverage

The test helps determine if patients with rheumatoid arthritis are unlikely to respond to anti-TNF therapies.

Rheumatoid arthritisBiologic therapyAnti tnfAnti tumor necrosis factorOint inflammationHealth insuranceIological markerAutoimmune diseasePrecision medicine

Do-It-Yourself Medications: Self-Injected Drugs on the Rise

We have people taking two or three different injectable drugs every other week.

La jollaUnited statesNadia ahmadJeffrey hackmanMedscape webEricj topolAmy hess fischlOwen mumford ltdScripps researchEli lilly companyEli lilly coGrandview researchComera life sciencesUniversity of chicagoJournal of pharmaceutical sciencesScripps research in la jolla

Biologic-to-Biosimilar Switches Deemed Safe and Effective

Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.

United statesBeatriz grosDrug administrationEuropean medicines agencyDigestive disease weekWestern general hospitalHarvey bradshaw indexInflammatory bowel diseaseNflammatory bowel disease ibdBiologic therapyBiosimilar drugsFollow on biologicsComputed tomographyIological markerSocial determinants of healthAnti tnf

MyJournals org - Science - IJMS, Vol 24, Pages 8695: Development of a Prediction Model for Short-Term Remission of Patients with Crohn s Disease Treated with Anti-TNF Drugs (International Journal of Molecular Sciences)

MyJournals.org - Science - IJMS, Vol. 24, Pages 8695: Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs (International Journal of Molecular Sciences)

Short termRohn rsquo sAnti tnf

Fewer Discontinuations With Infliximab for UC Maintenance Tx

Researchers compared the rates of discontinuation after 1 year due to lack of efficacy.

United statesRegion flamandeMarc ferranteJoshuam steinbergUniversity of colorado school medicineUniversity hospitals leuvenMedscape medicalDigestive disease weekColorado schoolDisease weekUlcerative colitisBiologic therapyMonoclonal antibodyBiosimilar drugsFollow on biologicsInflammatory bowel disease

vimarsana © 2020. All Rights Reserved.